GRI Bio, Inc.
GRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $26 | $437 | $90,162 |
| - Cash | $5 | $2 | $0 | $4 |
| + Debt | $0 | $0 | $1 | $0 |
| Enterprise Value | -$2 | $25 | $438 | $90,158 |
| Revenue | $23 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $11 | $0 | $0 | $0 |
| % Margin | 48.4% | – | – | – |
| EBITDA | -$8 | -$11 | -$3 | -$1 |
| % Margin | -36.5% | – | – | – |
| Net Income | -$8 | -$13 | -$3 | -$2 |
| % Margin | -36.4% | – | – | – |
| EPS Diluted | -55.21 | -6,242.18 | -165,346 | -815.8 |
| % Growth | 99.1% | 96.2% | -20,168% | – |
| Operating Cash Flow | -$9 | -$9 | -$1 | -$8 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$9 | -$9 | -$1 | -$8 |